Jesse Solomon

On October 20, 2016, the Federal Trade Commission (“FTC”) and Department of Justice: Antitrust Division (“DOJ”) jointly issued antitrust law guidance for human resource profession...

In a closely watched case that has been pending in the federal courts for over a decade—a series of private lawsuits alleging that Chinese manufacturers had colluded to fix prices of vi...

On June 29, 2016, the Federal Trade Commission (“FTC”) announced an increase in the maximum civil penalties it may impose for violations of the Hart-Scott-Rodino Act (“HSR Act”) a...

A team of attorneys from Davis Polk & Wardwell LLP presented the ABA’s January Antitrust Update for In-House Counsel. The following article summarizes one of the recent developments dis...

THIS PAST SPRING, A NEW YORK JURY found Chinese manufacturers of vitamin C liable for fixing prices of exports from China into the United States, in violation of U.S. antitrust laws. In t...

After more than a decade of litigation in the lower courts, the Supreme Court yesterday heard oral argument in a case of considerable consequence to the pharmaceutical industry. The issue...

Looking back at 2012, four years after China implemented its Anti-Monopoly Law (“AML”), we can discern some important ways in which China’s antitrust regime today both mirrors and d...

New political administrations often come into office with assumptions, and sometimes clear statements, about how their approach to antitrust enforcement will differ from that of their pre...

As we have previously discussed, the Securities and Exchange Commission (“SEC”) Director of Enforcement Robert Khuzami recently unveiled new tools designed to help the SEC Staff accel...

An uptick in mergers and acquisitions has led to more litigation seeking to stop the deals As 2009 has progressed, we have seen the return of significant public company mergers and acqui...